These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 15174860)

  • 21. Orientation and affinity of HIV-1 Tat fragments in Tat-TAR complex determined by fluorescence resonance energy transfer.
    Cao H; Tamilarasu N; Rana TM
    Bioconjug Chem; 2006; 17(2):352-8. PubMed ID: 16536465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular dynamics and binding specificity analysis of the bovine immunodeficiency virus BIV Tat-TAR complex.
    Reyes CM; Nifosì R; Frankel AD; Kollman PA
    Biophys J; 2001 Jun; 80(6):2833-42. PubMed ID: 11371457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparative binding study of BIV Tat peptide against its TAR RNA duplex, RNA-DNA heteroduplex and DNA duplex.
    Tok JB; Bi L
    Bioorg Med Chem Lett; 2005 Jan; 15(1):129-33. PubMed ID: 15582425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A single intermolecular contact mediates intramolecular stabilization of both RNA and protein.
    Calabro V; Daugherty MD; Frankel AD
    Proc Natl Acad Sci U S A; 2005 May; 102(19):6849-54. PubMed ID: 15857951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polyamidoamine dendrimers inhibit binding of Tat peptide to TAR RNA.
    Zhao H; Li J; Xi F; Jiang L
    FEBS Lett; 2004 Apr; 563(1-3):241-5. PubMed ID: 15063756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stem-loop SL4 of the HIV-1 psi RNA packaging signal exhibits weak affinity for the nucleocapsid protein. structural studies and implications for genome recognition.
    Amarasinghe GK; Zhou J; Miskimon M; Chancellor KJ; McDonald JA; Matthews AG; Miller RR; Rouse MD; Summers MF
    J Mol Biol; 2001 Dec; 314(5):961-70. PubMed ID: 11743714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Solution structure of a bovine immunodeficiency virus Tat-TAR peptide-RNA complex.
    Puglisi JD; Chen L; Blanchard S; Frankel AD
    Science; 1995 Nov; 270(5239):1200-3. PubMed ID: 7502045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular recognition in the bovine immunodeficiency virus Tat peptide-TAR RNA complex.
    Ye X; Kumar RA; Patel DJ
    Chem Biol; 1995 Dec; 2(12):827-40. PubMed ID: 8807816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural model of the HIV-1 Tat(46-58)-TAR complex.
    Seewald MJ; Metzger AU; Willbold D; Rösch P; Sticht H
    J Biomol Struct Dyn; 1998 Dec; 16(3):683-92. PubMed ID: 10052624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simultaneous recognition of HIV-1 TAR RNA bulge and loop sequences by cyclic peptide mimics of Tat protein.
    Davidson A; Leeper TC; Athanassiou Z; Patora-Komisarska K; Karn J; Robinson JA; Varani G
    Proc Natl Acad Sci U S A; 2009 Jul; 106(29):11931-6. PubMed ID: 19584251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new class of HIV-1 Tat antagonist acting through Tat-TAR inhibition.
    Hamy F; Brondani V; Flörsheimer A; Stark W; Blommers MJ; Klimkait T
    Biochemistry; 1998 Apr; 37(15):5086-95. PubMed ID: 9548739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RNA recognition and regulation of HIV-1 gene expression by viral factor Tat.
    Naryshkin NA; Gait MJ; Ivanovskaya MG
    Biochemistry (Mosc); 1998 May; 63(5):489-503. PubMed ID: 9632883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional significance of the dinucleotide bulge in stem-loop1 and stem-loop2 of HIV-2 TAR RNA.
    Rhim H; Rice AP
    Virology; 1994 Jul; 202(1):202-11. PubMed ID: 8009832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selection of TAR RNA-binding chameleon peptides by using a retroviral replication system.
    Xie B; Calabro V; Wainberg MA; Frankel AD
    J Virol; 2004 Feb; 78(3):1456-63. PubMed ID: 14722301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An RNA-binding chameleon.
    Smith CA; Calabro V; Frankel AD
    Mol Cell; 2000 Nov; 6(5):1067-76. PubMed ID: 11106746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding of neomycin to the TAR element of HIV-1 RNA induces dissociation of Tat protein by an allosteric mechanism.
    Wang S; Huber PW; Cui M; Czarnik AW; Mei HY
    Biochemistry; 1998 Apr; 37(16):5549-57. PubMed ID: 9548939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An Arg/Lys-rich core peptide mimics TRBP binding to the HIV-1 TAR RNA upper-stem/loop.
    Erard M; Barker DG; Amalric F; Jeang KT; Gatignol A
    J Mol Biol; 1998 Jun; 279(5):1085-99. PubMed ID: 9642086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure-based drug design targeting an inactive RNA conformation: exploiting the flexibility of HIV-1 TAR RNA.
    Murchie AI; Davis B; Isel C; Afshar M; Drysdale MJ; Bower J; Potter AJ; Starkey ID; Swarbrick TM; Mirza S; Prescott CD; Vaglio P; Aboul-ela F; Karn J
    J Mol Biol; 2004 Feb; 336(3):625-38. PubMed ID: 15095977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Replication of human immunodeficiency viruses engineered with heterologous Tat-transactivation response element interactions.
    Xie B; Wainberg MA; Frankel AD
    J Virol; 2003 Feb; 77(3):1984-91. PubMed ID: 12525632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluorescence correlation spectroscopy at single molecule level on the Tat-TAR complex and its inhibitors.
    Nandi CK; Parui PP; Brutschy B; Scheffer U; Göbel M
    Biopolymers; 2008 Jan; 89(1):17-25. PubMed ID: 17764074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.